Anthem, Deutsche Bank, Nio, Synchrony Financial and More Friday Afternoon Analyst Calls24/7 Wall Street • 07/09/21
Nevro Announces SENZA-NSRBP Clinical Data Presentation at the American Society of Interventional Pain Physicians 23rd Annual MeetingPRNewsWire • 06/22/21
Nevro Announces SENZA-PDN Clinical Data Presentation at the American Diabetes Association 81st Scientific SessionsPRNewsWire • 06/22/21
Nevro Corp. (NVRO) CEO Keith Grossman on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/09/21
Nevro Introduces HFX, New Comprehensive Brand Identity Combining Nevro's Innovative Technologies, Advanced Therapies and End-to-End Patient SupportPRNewsWire • 04/26/21
Nevro Announces Publication Of Landmark SENZA-PDN Clinical Trial Results In JAMA NeurologyPRNewsWire • 04/05/21
Nevro Corp (NVRO) CEO Keith Grossman on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/25/21
Nevro (NVRO) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 02/17/21
Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® TherapyPRNewsWire • 01/19/21